SAN
DIEGO, June 1, 2023 /PRNewswire/ -- Aethlon
Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused
on developing products to diagnose and treat cancer and
life-threatening infectious diseases, today announced that
Guy Cipriani, Senior Vice President
and Chief Business Officer, and James
Frakes, Chief Financial Officer, will present a company
overview at the 13th Annual LD Micro Invitational on Wednesday, June 7, 2023, at 1:30 PM PT.
Management will also be participating in one-on-one meetings
with investors at this conference being held June 6-8, 2023, in Los
Angeles, California. To schedule a meeting with management
outside of the conference, contact Susan
Noonan at susan@sanoonan.com.
Interested parties can register to watch the presentation
virtually here.
To register to attend the LD Micro conference, please contact
Dean@ldmicro.com.
About Aethlon and the Hemopurifier®
Aethlon Medical is a medical therapeutic company focused on
developing the Hemopurifier, a clinical stage immunotherapeutic
device which is designed to combat cancer and life-threatening
viral infections. In human studies, the Hemopurifier has
demonstrated the removal of life-threatening viruses and harmful
exosomes from blood utilizing its proprietary lectin-based
technology. This action has potential applications in cancer, where
exosomes may promote immune suppression and metastasis, and in
life-threatening infectious diseases.
The Hemopurifier is a U.S. Food and Drug Administration (FDA)
designated Breakthrough Device indicated for the treatment of
individuals with advanced or metastatic cancer who are either
unresponsive to or intolerant of standard of care therapy, and with
cancer types in which exosomes have been shown to participate in
the development or severity of the disease. The Hemopurifier also
holds an FDA Breakthrough Device designation and an open
Investigational Device Exemption (IDE) application related to the
treatment of life-threatening viruses that are not addressed with
approved therapies.
Additional information can be found at
www.AethlonMedical.com.
Company Contact:
Jim Frakes
Chief Financial Officer
Aethlon Medical, Inc.
Jfrakes@aethlonmedical.com
Investor Contact:
Susan Noonan
S.A. Noonan Communications, LLC
susan@sanoonan.com
917-513-5303
View original
content:https://www.prnewswire.com/news-releases/aethlon-medical-to-present-at-the-13th-annual-ld-micro-invitational-301840647.html
SOURCE Aethlon Medical, Inc.